Insiders sold more Tempus AI (TEM) stock last week as shares of the medical technology firm continue to notch a series of fresh all-time highs.

PhaseV, a pioneer in software and machine learning (ML) for advanced clinical development optimization, announced today the launch of its new webinar series exploring the latest innovations in ...

USA News Group News CommentaryIssued on behalf of Avant Technologies Inc. VANCOUVER, BC, Feb. 11, 2025 /PRNewswire/ -- USA News Group News Commentary - Weeks after the monumental ...

Beyond Stargate's big players, a growing number of innovators have been revolutionizing healthcare by making recent ...

Dave Bartosiak's technical analysis approach adds depth to our understanding Tempus AI stock chart. By paying attention to moving averages, support and resistance levels, chart patterns ...

Dave Bartosiak's technical analysis approach adds depth to our understanding Tempus AI stock chart. By paying attention to moving averages, support and resistance levels, chart patterns, technical ...

In this article, we are going to take a look at where Tempus AI Inc. (NASDAQ:TEM) stands against the other stocks. Optimistic sentiment continued to drive Wall Street on Thursday, with all major ...

Tempus AI (NASDAQ:TEM) wasn’t that remarkable compared to most other AI high-fliers in the past year. The stock was very volatile in the past year and declined significantly in December 2024.

Tempus AI, Inc. (NASDAQ:TEM – Get Free Report)’s stock price dropped 4.1% during trading on Monday following insider selling activity. The stock traded as low as $48.08 and last traded at $49.31.

And shares of med-tech company Tempus AI (TEM) soared last week after it released olivia, its AI-power health concierge. The pivot from infrastructure to application may have been hastened by ...